These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3056533)

  • 1. E. coli infections of the lower urinary tract and their treatment by immunomodulation or combined immunomodulation and antigen therapy.
    Mathieu D; Jacques L; Auer J; Bizzini B
    Biomed Pharmacother; 1988; 42(4):271-7. PubMed ID: 3056533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of an immunomodulator (P40) on Escherichia coli urinary infection in the rat].
    Mathieu D; Fries D; Auer J; Bizzini B; Jacques L
    Biomed Pharmacother; 1982; 36(10):420-5. PubMed ID: 6764138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
    Mathieu D; Jacques L; Auer J; Bizzini B
    Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary Escherichia coli infections in the rat. Significance of the study of antibody-coated bacteria].
    Jacques L; Mathieu D; Begle P; Fries D
    Biomedicine; 1980; 33(5):156-9. PubMed ID: 7002226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of induced urinary tract infection: an animal model to assess bladder immunization.
    Jensen J; Balish E; Mizutani K; Uehling DT
    J Urol; 1982 Jun; 127(6):1220-2. PubMed ID: 7045407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local autovaccine treatment of experimental urinary tract infections in the rat].
    Straube E; Broschewitz U
    Z Urol Nephrol; 1988 Jan; 81(1):1-12. PubMed ID: 3284238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Escherichia coli O antigen in upper urinary tract infection.
    Whitworth JA; Fairley KF; O'Keefe CM; Miller TE
    Kidney Int; 1975 Nov; 8(5):316-9. PubMed ID: 1104969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of O antigens and antibodies during urinary tract infections due to Escherichia coli (author's transl)].
    Fries D; Renault L; Mathieu D; Charpentier B; Guerin D; Jacques L
    Nouv Presse Med; 1979 Mar; 8(15):1239-43. PubMed ID: 375188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary tract infections and their prevention].
    González-Chamorro F; Palacios R; Alcover J; Campos J; Borrego F; Dámaso D
    Actas Urol Esp; 2012 Jan; 36(1):48-53. PubMed ID: 21757260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [O antigen factors in Escherichia coli 01 strains of patients with urinary tract infections].
    Zingler G; Nimmich W; Naumann G; Falkenhagen U; Straube E; Ulisko IN; Ratiner YuA ; Golubeva IV
    Z Gesamte Hyg; 1985 Jan; 31(1):44-6. PubMed ID: 2580398
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of canine pyometra.
    Sandholm M; Vasenius H; Kivistö AK
    J Am Vet Med Assoc; 1975 Dec; 167(11):1006-10. PubMed ID: 1104545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
    Tasdemir S; Tasdemir C; Vardi N; Yakupogullari Y; Duman Y; Parlakpinar H; Sagir M; Acet A
    Int J Urol; 2012 Dec; 19(12):1108-12. PubMed ID: 22852837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the effect of K antigen in Escherichia coli urinary tract infections by use of a mouse model.
    Nicholson AM; Glynn AA
    Br J Exp Pathol; 1975 Dec; 56(6):549-53. PubMed ID: 769819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and therapy of urinary tract infections of childhood.
    Wientzen RL; McCracken GH; Petruska ML; Swinson SG; Kaijser B; Hanson LA
    Pediatrics; 1979 Mar; 63(3):467-74. PubMed ID: 375176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological approach to the pathogenetical role of Escherichia coli adhesive factor "119" in a suckling mouse urinary tract model.
    Kétyi I
    Acta Microbiol Acad Sci Hung; 1982; 29(2):123-7. PubMed ID: 6127911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of antibody coated bacteria in the evaluation of the level of urinary tract infections].
    Demirağ MN; Atun IH; Gülmezoğlu E
    Mikrobiyol Bul; 1982 Jan; 16(1):43-52. PubMed ID: 6755199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [O-antigen factors and mannose-resistant hemagglutination in relation to the O:K:H serotype of Escherichia coli 02 strains in patients with urinary tract infections].
    Zingler G; Nimmich W; Falkenhagen U; Becziczka B; Ulisko IN; Ratiner YA
    Z Gesamte Hyg; 1986 Oct; 32(10):595-8. PubMed ID: 2433841
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between the O:K:H serotype and the fimbria antigen in E. coli of urinary tract infections].
    Nimmich W; Zingler G
    Z Urol Nephrol; 1984 Jun; 77(6):343-9. PubMed ID: 6206664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary infections in children].
    Denis R; De Meuter F
    Arch Fr Pediatr; 1978; 35(7):726-36. PubMed ID: 367309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.